{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T02:14:49Z","timestamp":1779934489757,"version":"3.53.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.forsciint.2009.10.014","type":"journal-article","created":{"date-parts":[[2009,11,20]],"date-time":"2009-11-20T16:18:00Z","timestamp":1258733880000},"page":"77-79","source":"Crossref","is-referenced-by-count":20,"title":["Postmortem molecular screening for mutations in ryanodine receptor type 1 (RYR1) gene in psychiatric patients suspected of having died of neuroleptic malignant syndrome"],"prefix":"10.1016","volume":"194","author":[{"given":"Takako","family":"Sato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Nishio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misa","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"KentoTsuboi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyoshi","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tokiko","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.forsciint.2009.10.014_bib1","first-page":"56","article-title":"A comparison of diagnostic criteria for neuroleptic malignant syndrome","volume":"53","author":"Gurrera","year":"1992","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.forsciint.2009.10.014_bib2","first-page":"1366","article-title":"Malignant neuroleptic syndrome, a review of epidemiology, risk factors, diagnosis, differential diagnosis and pathogenesis of MNS","volume":"162","author":"Andreassen","year":"2000","journal-title":"Ugeskr. Laeger"},{"key":"10.1016\/j.forsciint.2009.10.014_bib3","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1056\/NEJM198308183090706","article-title":"The malignant hyperthermia syndrome","volume":"309","author":"Nelson","year":"1983","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.forsciint.2009.10.014_bib4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2174\/1566524023362429","article-title":"Malignant hyperthermia: a pharmacogenetic disease of Ca++ regulation proteins","volume":"2","author":"Nelson","year":"2002","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.forsciint.2009.10.014_bib5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/(SICI)1097-4598(200001)23:1<4::AID-MUS3>3.0.CO;2-D","article-title":"Genetics and pathogenesis of malignant hyperthermia","volume":"23","author":"Jurkat-Rott","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.forsciint.2009.10.014_bib6","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/(SICI)1098-1004(200005)15:5<410::AID-HUMU2>3.0.CO;2-D","article-title":"Ryanodine receptor mutations in malignant hyperthermia and central core disease","volume":"15","author":"McCarthy","year":"2000","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.forsciint.2009.10.014_bib7","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/00000542-200606000-00008","article-title":"Malignant hyperthermia in Japan","volume":"104","author":"Ibarra","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1016\/j.forsciint.2009.10.014_bib8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00002826-200207000-00001","article-title":"Is neuroleptic malignant syndrome a neurogenic form of malignant hyperthermia?","volume":"25","author":"Gurrera","year":"2002","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.forsciint.2009.10.014_bib9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0022-510X(96)00015-9","article-title":"No association between the neuroleptic malignant syndrome and mutations in the RYR1 gene associated malignant hyperthermia","volume":"143","author":"Miyatake","year":"1996","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.forsciint.2009.10.014_bib10","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.nmd.2005.06.008","article-title":"Ryanodine receptor 1 mutations, dysregulation of calcium homeostasis and neuromuscular disorders","volume":"15","author":"Treves","year":"2005","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.forsciint.2009.10.014_bib11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.forsciint.2004.06.011","article-title":"Three cases of suspected hyperthermia with remarkable elevation of serum mast cell tryptase","volume":"149","author":"Nishio","year":"2005","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2009.10.014_bib12","first-page":"78","article-title":"The obscure autopsy and neuroleptic malignant syndrome","volume":"37","author":"Lowe","year":"1997","journal-title":"Med. Sci. Law"},{"key":"10.1016\/j.forsciint.2009.10.014_bib13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/01.paf.0000137345.49901.93","article-title":"Pathologic findings in malignant hyperthermia: a case report and review of literature","volume":"25","author":"Christiansen","year":"2004","journal-title":"Am. J. Forensic Med. Pathol."},{"key":"10.1016\/j.forsciint.2009.10.014_bib14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0025-7125(16)30278-4","article-title":"Neuroleptic malignant syndrome","volume":"77","author":"Caroff","year":"1993","journal-title":"Med. Clin. North Am."},{"key":"10.1016\/j.forsciint.2009.10.014_bib15","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/0888-7543(91)90084-R","article-title":"A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia","volume":"11","author":"Gillard","year":"1991","journal-title":"Genomics"},{"key":"10.1016\/j.forsciint.2009.10.014_bib16","doi-asserted-by":"crossref","first-page":"9413","DOI":"10.1016\/S0021-9258(17)36895-3","article-title":"The point mutation Arg615\u2192Cys in the Ca2+ release channel of skeletal sarcoplasmic reticulum is responsible for hypersensitivity to caffeine and halothane in malignant hyperthermia","volume":"269","author":"Otsu","year":"1994","journal-title":"J. Biol. Chem."}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073809004253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073809004253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T14:36:07Z","timestamp":1634222167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0379073809004253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":16,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0379073809004253"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2009.10.014","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}